Browse studies
Find your next paid study
3 recruiting studies matching your filters
Phase 2
A Phase II Study of Ivonescimab Combined With Intraperitoneal Paclitaxel in Patients With High-Grade Metastatic Appendiceal Adenocarcinoma (AA)
To evaluate the safety and effectiveness of Ivonescimab combined with intraperitoneal paclitaxel (IP PTX) in patients with unresectable metastatic high-grade A…
Phase IIIvonescimabIntraperitoneal+3 more
Estimated
~$10 – $6,250
M.D. Anderson Cancer CenterNCT07753824
Phase 2
Phase II Trial of Ivonescimab in Previously Treated Patients With Advanced Clear Cell Renal Cell Carcinoma
To learn if ivonescimab can help to control previously treated, locally advanced or metastatic ccRCC.
IvonescimabClear Cell Renal Carcinoma
Estimated
~$10 – $6,250
M.D. Anderson Cancer CenterNCT06940518
Phase 2
STOMP OUT: A Phase 2 Study To Evaluate The Effects Of Ivonescimab In Patients With Unresectable/Metastatic Adrenocortical Carcinoma (ACC) Or Unresectable Pheochromocytoma/Paraganglioma (PPGL)
To learn if ivonescimab can help to control previously treated, locally advanced or metastatic ACC or PPGL.
Phase IIIvonescimabEvaluate+4 more
Estimated
~$10 – $6,250
M.D. Anderson Cancer CenterNCT07743138